首页 | 本学科首页   官方微博 | 高级检索  
检索        

摄涕止鼽颗粒治疗常年性变应性鼻炎42例临床观察
引用本文:彭顺林,钟渠,袁晓辉.摄涕止鼽颗粒治疗常年性变应性鼻炎42例临床观察[J].中医杂志,2004,45(11):836-837.
作者姓名:彭顺林  钟渠  袁晓辉
作者单位:1. 成都中医药大学,四川省成都市十二桥路37号,610075
2. 四川省绵阳市第四人民医院
摘    要:目的:观察摄涕止鼽颗粒治疗常年性变应性鼻炎(PAR)的疗效.方法:78例常年性变应性鼻炎患者随机分为两组,治疗组42例应用摄涕止鼽颗粒,对照组36例应用抗组胺药氯雷他定.结果:治疗组有效率为90.48%,对照组有效率为94.44%,两组疗效比较无显著性差异(P>0.05);而治疗组远期疗效的有效率为84.21%,对照组的有效率为54.55%,两组远期疗效有显著性差异(P<0.05).结论:摄涕止鼽颗粒为临床治疗PAR的有效制剂,且远期疗效稳定,优于西药.

关 键 词:鼻炎  变应性  常年性/中医药疗法  @  摄涕止鼽颗粒

Clinical Observation on 42 Cases of Perennial Allergic Rhinitis Treated by Sheti Zhiqiu Granules
Peng Shunlin,Zhong Qu,Yuan Xiaohui.Clinical Observation on 42 Cases of Perennial Allergic Rhinitis Treated by Sheti Zhiqiu Granules[J].Journal of Traditional Chinese Medicine,2004,45(11):836-837.
Authors:Peng Shunlin  Zhong Qu  Yuan Xiaohui
Institution:Peng Shunlin~1,Zhong Qu~2,Yuan Xiaohui~1
Abstract:Objective: To observe the curative effect of Sheti Zhiqiu Granules on perennial allergic rhinitis (PAR). Methods: 78 cases of PAR were randomly divided into 2 groups. The treatment group of 42 cases were treated by Sheti Zhiqiu Granules and the control group of 36 cases by antihistamin agent Loratadine. Results: The effective rate was 90. 48% in the treatment group and 94. 44% in the control group with no significantly difference between the two groups (P>0. 05); The long-term effective rate was 84. 21% in the treatment group and 54. 55% in the control group with a significant difference between the two groups (P<0. 05). Conclusion: Sheti Zhiqiu Granules is effective for clinical treatment of PAR, with a stable long-term therapeutic effect, superior to Loratatine.
Keywords:Rhinitis  Allergic  Perennial/TCM therapy  @Sheti Zhiqiu Granules  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号